Shankar Musunuri

Title: Shankar Musunuri: Innovator in Pharmaceutical Formulations

Introduction

Shankar Musunuri is a notable inventor based in Exton, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of amylin agonist peptides. With a total of 2 patents, his work focuses on improving the stability and efficacy of these formulations for patient administration.

Latest Patents

Musunuri's latest patents include innovative formulations for amylin agonist peptides. The first patent describes a pharmaceutical formulation that comprises approximately 0.01 to about 0.5% (w/v) amylin agonist, preferably pramlintide, in an aqueous system. This formulation also includes a buffer to maintain a pH of approximately 3.0 to about 6.0, along with a carbohydrate or polyhydric alcohol tonicifier. The formulation is designed to maintain stability under both refrigerated and room temperature conditions. Additionally, it can be combined with insulin in the same syringe for administration to patients.

The second patent focuses on amylin agonist pharmaceutical compositions containing insulin. Similar to the first, this formulation includes approximately 0.01 to about 0.5% (w/v) amylin agonist and a buffer to maintain the desired pH. It also incorporates a carbohydrate or polyhydric alcohol tonicifier and a preservative. This formulation is also designed to maintain stability during storage and can be administered alongside insulin.

Career Highlights

Shankar Musunuri is currently associated with Amylin Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceutical formulations. His work has been instrumental in advancing the understanding and application of amylin agonist peptides in medical treatments.

Collaborations

Musunuri has collaborated with notable colleagues such as James J L'Italien and Kale Ruby. These collaborations have contributed to the development of effective pharmaceutical solutions.

Conclusion

Shankar Musunuri's contributions to pharmaceutical formulations, particularly in the area of amylin agonist peptides, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical science through effective and stable formulations.